{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:28:10Z","timestamp":1791952090630,"version":"4.3.4"},"publisher-location":"New York, NY","reference-count":10,"publisher":"Springer US","isbn-type":[{"value":"9781071635407","type":"print"},{"value":"9781071635414","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3541-4_14","type":"book-chapter","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:27:05Z","timestamp":1701390425000},"page":"141-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determination of Busulfan and Melphalan in Plasma by Turbulent Flow Chromatography-Tandem Mass Spectrometry"],"prefix":"10.1007","author":[{"given":"Ryan C.","family":"Schofield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Scordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean C.","family":"Carlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"issue":"7","key":"14_CR1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.bbmt.2011.12.584","volume":"18","author":"JB Perkins","year":"2012","unstructured":"Perkins JB, Kim J, Anasetti C, Fernandez HF, Perez LE, Ayala E, Kharfan-Dabaja MA, Tomblyn MR, Sullivan DM, Pidala JA, Field TL (2012) Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 18(7):1099\u20131107","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"14_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-3-36","volume":"3","author":"J Pidala","year":"2010","unstructured":"Pidala J, Kim J, Anasetti C, Kharfan-Dabaja MA, Nishihori T, Field T, Perkins J, Perez L, Fernandez HF (2010) Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia. J Hematol Oncol 3(1):1\u20139","journal-title":"J Hematol Oncol"},{"issue":"8","key":"14_CR3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.bbmt.2012.02.006","volume":"18","author":"H Zhang","year":"2012","unstructured":"Zhang H, Graiser M, Hutcherson DA, Dada MO, McMillan S, Ali Z, Flowers CR, Waller EK (2012) Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation. Biol Blood Marrow Transplant 18(8):1287\u20131294","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"14_CR4","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1016\/j.bbmt.2011.12.014","volume":"18","author":"PJ Shaw","year":"2012","unstructured":"Shaw PJ, Nath CE, Nivison-Smith I, Joshua DE, Kerridge IH, Presgrave P, Tiley CR, Kwan YL, Trotman J (2012) Higher melphalan exposure is associated with improved overall survival for myeloma patients undergoing autologous transplant. Biol Blood Marrow Transplant 18(2):S207","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"14_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bbmt.2010.07.016","volume":"17","author":"P Kebriaei","year":"2011","unstructured":"Kebriaei P, Madden T, Kazerooni R, Wang X, Thall PF, Ledesma C, Nieto Y, Shpall EJ, Hosing C, Qazilbash M, Popat U (2011) Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies. Biol Blood Marrow Transplant 17(3):412\u2013420","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"14_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbmt.2012.09.003","volume":"19","author":"JD Goldberg","year":"2013","unstructured":"Goldberg JD, Linker A, Kuk D, Ratan R, Jurcic J, Barker JN, Castro-Malaspina H, Giralt S, Hsu K, Jakubowski AA, Jenq R (2013) T cell\u2013depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. Biol Blood Marrow Transplant 19(2):208\u2013213","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"14_CR7","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.bbmt.2011.01.005","volume":"17","author":"AA Jakubowski","year":"2011","unstructured":"Jakubowski AA, Small TN, Kernan NA, Castro-Malaspina H, Collins N, Koehne G, Hsu KC, Perales MA, Papanicolaou G, van den Brink MR, O\u2019Reilly RJ (2011) T cell\u2013depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. Biol Blood Marrow Transplant 17(9):1335\u20131342","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"14_CR8","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.bbmt.2015.07.010","volume":"21","author":"R Tamari","year":"2015","unstructured":"Tamari R, Chung SS, Papadopoulos EB, Jakubowski AA, Hilden P, Devlin SM, Goldberg JD, Perales MA, Ponce DM, Sauter CS, Maloy MA (2015) CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and antithymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus-host disease without increased relapse. Biol Blood Marrow Transplant 21(12):2106\u20132114","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR9","first-page":"399","volume":"130","author":"MH Qazilbash","year":"2017","unstructured":"Qazilbash MH, Bashir Q, Thall PF, Milton DR, Shah N, Patel KK, Andersson BS, Nieto Y, Kebriaei P, Valdez BC, Kawedia J (2017) A randomized phase III trial of busulfan+ melphalan vs melphalan alone for multiple myeloma. Blood 130:399","journal-title":"Blood"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jchromb.2015.08.025","volume":"1002","author":"RC Schofield","year":"2015","unstructured":"Schofield RC, Ramanathan LV, Murata K, Grace M, Fleisher M, Pessin MS, Carlow DC (2015) Development and validation of a turbulent flow chromatography and tandem mass spectrometry method for the quantitation of methotrexate and its metabolites 7-hydroxy methotrexate and DAMPA in serum. J Chromatogr B 1002:169\u2013175","journal-title":"J Chromatogr B"}],"container-title":["Methods in Molecular Biology","Clinical Applications of Mass Spectrometry in Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3541-4_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:32:26Z","timestamp":1701390746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3541-4_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"ISBN":["9781071635407","9781071635414"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3541-4_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"1 December 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}